Th17 and non-classic Th1 cells in chronic inflammatory disorders: Two sides of the same coin

International Archives of Allergy and Immunology

Volumn 164, Issue 3, 2014, Pages 171-177

  Cosmi, Lorenzo ^a   Liotta, Francesco ^a   Maggi, Enrico ^a   Romagnani, Sergio ^a   Annunziato, Francesco ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Asthma; Autoimmunity; Th1 cells; Th17 cells; Tumor necrosis factor

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 26; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TUMOR NECROSIS FACTOR ALPHA;

CELL DIFFERENTIATION; CHRONIC DISEASE; CONTACT DERMATITIS; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE COURSE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY DISEASE; JUVENILE RHEUMATOID ARTHRITIS; LYMPHOCYTE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PHENOTYPE; PROTEIN FUNCTION; PSORIASIS; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; TH1 CELL; TH17 CELL; ANTAGONISTS AND INHIBITORS; AUTOIMMUNITY; IMMUNOLOGY; INFLAMMATION; PATHOLOGY; SKIN ALLERGY; T LYMPHOCYTE SUBPOPULATION;

ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; CELL DIFFERENTIATION; CHRONIC DISEASE; CROHN DISEASE; DERMATITIS, ALLERGIC CONTACT; HUMANS; INFLAMMATION; INTERLEUKIN-12; MULTIPLE SCLEROSIS; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH17 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84904273540     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000363502     Document Type: Review

References (47)

1. Cosmi L, Maggi L, Santarlasci V, Liotta F, Annunziato F: T helper cells plasticity in inflammation. Cytometry A 2014; 85: 36-42.
2. Mosmann TR, Coffman RL: TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145-173.
3. Romagnani S: Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994; 12: 227-257.
4. Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S: Defining the human T helper 17 cell phenotype. Trends Immunol 2012; 33: 505-512.
5. Honda K: IL-22 from T cells: better late than never. Immunity 2012; 37: 952-954.
6. Jabeen R, Kaplan MH: The symphony of the ninth: the development and function of Th9 cells. Curr Opin Immunol 2012; 24: 303-307.
7. King C, Tangye SG, Mackay CR: T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu Rev Immunol 2008; 26: 741-766.
8. Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S: Main features of human T helper 17 cells. Ann NY Acad Sci 2013; 1284: 66-70.
9. Gately MK, Renzetti LM, Magram J, et al: The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 1998; 16: 495-521.
10. Chen Z, OShea JJ: Th17 cells: a new fate for differentiating helper T cells. Immunol Res 2008; 41: 87-102.
11. Annunziato F, Cosmi L, Romagnani S: Human and murine Th17. Curr Opin HIV AIDS 2010; 5: 114-119.
12. Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B, Parente E, Fili L, Ferri S, Frosali F, Giudici F, Romagnani P, Parronchi P, Tonelli F, Maggi E, Romagnani S: Phenotypic and functional features of human Th17 cells. J Exp Med 2007; 204: 1849-1861.
13. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR: The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006; 126: 1121-1131.
14. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A, Sallusto F, Napolitani G: Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 2007; 8: 639-646.
15. Cosmi L, De Palma R, Santarlasci V, Maggi L, Capone M, Frosali F, Rodolico G, Querci V, Abbate G, Angeli R, et al: Human interleukin-17-producing cells originate from a CD161+ CD4+ T cell precursor. J Exp Med 2008; 205: 1903-1916.
16. Santarlasci V, Maggi L, Capone M, Frosali F, Querci V, De Palma R, Liotta F, Cosmi L, Maggi E, Romagnani S, et al: TGF-beta indirectly favors the development of human Th17 cells by inhibiting Th1 cells. Eur J Immunol 2009; 39: 207-215.
17. de Beaucoudrey L, Puel A, Filipe-Santos O, Cobat A, Ghandil P, Chrabieh M, Feinberg J, von Bernuth H, Samarina A, Janniere L, et al: Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med 2008; 205: 1543-1550.
18. Ghoreschi K, Laurence A, Yang XP, Tato CM, McGeachy MJ, Konkel JE, Ramos HL, Wei L, Davidson TS, Bouladoux N, et al: Generation of pathogenic T(H)17 cells in the absence of TGF-β signaling. Nature 2010; 467: 967-971.
19. Miossec P, Kolls JK: Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov 2012; 11: 763-776.
20. Ouyang W, Koli JK, Zheng Y: The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008; 28: 454-467.
21. Pelletier M, Maggi L, Micheletti A, Lazzeri E, Tamassia N, Costantini C, Cosmi L, Lunardi C, Annunziato F, Romagnani S, et al: Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 2010; 115: 335-343.
22. Chen Y, Thai P, Zhao YH, Ho YS, DeSouza MM, Wu R: Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J Biol Chem 2003; 278: 17036-17043.
23. Kao CY, Chen Y, Thai P, Wachi S, Huang F, Kim C, Harper RW, Wu R: IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NFkappaB signalling pathways. J Immunol 2004; 173: 3482-3491.
24. Kao CY, Huang F, Chen Y, Thai P, Wachi S, Kim C, et al: Up-regulation of CC chemokine ligand 20 expression in human airway epithelium by IL-17 through a JAK-independent but MEK/NF-kappaB-dependent signalling pathway. J Immunol 2005; 175: 6676-6685.
25. Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM, Kanno Y, Spalding C, Elloumi HZ, Paulson ML, Davis J, Hsu A, Asher AI, OShea J, Holland SM, Paul WE, Douek DC: Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008; 452: 773-776.
26. McDonald DR: TH17 deficiency in human disease. J Allergy Clin Immunol 2012; 129: 1429-1435.
27. Fouser LA, Wright JF, Dunussi-Joannopoulos K, Collins M: Th17 cytokines and their emerging roles in inflammation and autoimmunity. Immunol Rev 2008; 226: 87-102.
28. Santarlasci V, Maggi L, Capone M, Querci V, Beltrame L, Cavalieri D, DAiuto E, Cimaz R, Nebbioso A, Liotta F, De Palma R, Maggi E, Cosmi L, Romagnani S, Annunziato F: Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion. Immunity 2012; 36: 201-214.
29. Santarlasci V, Maggi L, Mazzoni A, Capone M, Querci V, Rossi MC, Beltrame L, Cavalieri D, De Palma R, Liotta F, Cosmi L, Maggi E, Romagnani S, Annunziato F: IL-4-induced gene 1 maintains high Tob1 expression which contributes to TCR unresponsiveness in human T helper 17 cells. Eur J Immunol 2014; 44: 654-661.
30. Annunziato F, Santarlasci V, Maggi L, Cosmi L, Liotta F, Romagnani S: Reasons for rarity of Th17 cells in inflammatory sites of human disorders. Semin Immunol 2013; 25: 299-304.
31. Zielinski CE, Mele F, Aschenbrenner D, Jarrossay D, Ronchi F, Gattorno M, Monticelli S, Lanzavecchia A, Sallusto F: Pathogen-induced human T(H)17 cells produce IFN-γ or IL-10 and are regulated by IL-1β. Nature 2012; 484: 514-518.
32. Maggi L, Santarlasci V, Capone M, Rossi MC, Querci V, Mazzoni A, et al: Distinctive features of classic and non-classic (Th17 derived) human Th1 cells. Eur J Immunol 2012; 42: 3180-3188.
33. Martin-Orozco N, Chung Y, Chang SH, Wang YH, Dong C: Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur J Immunol 2009; 39: 216-224.
34. Bending D, De la Pena H, Veldhoen M, Phillips JM, Uyttenhove C, Stockinger B, Cooke A: Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest 2009; 119: 565-572.
35. Papp KA, Langley RG, Lebwohl M, Krueger GG, Szapary P, Yeilding N, Guzzo C, Hsu MC, Wang Y, Li S, et al: Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2). Lancet 2008; 371: 1675-1684.
36. Goldminz AM, Gottlieb AB: Ustekinumab for psoriasis and psoriatic arthritis. J Rheumatol 2012; 89: 86-89.
37. Luger D, Silver PB, Tang J, Cua D, Chen Z, Iwakura Y, Bowman EP, Sgambellone NM, Chan CC, Caspi RR: Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 2008; 205: 799-810.
38. Nistala K, Adams S, Cambrook H, Ursu S, Olivito B, de Jager W, Evans JG, Cimaz R, Bajaj-Elliott M, Wedderburn LR: Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc Natl Acad Sci USA 2010; 107: 14751-14756.
39. Cosmi L, Cimaz R, Maggi L, Santarlasci V, Capone M, Borriello F, Frosali F, Querci V, Simonini G, Barra G, et al: Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis. Arthritis Rheum 2011; 63: 2504-2515.
40. Maggi L, Cimaz R, Capone M, Santarlasci V, Querci V, Simonini G, Nencini F, Liotta F, Romagnani S, Maggi E, et al: Brief report: etanercept inhibits the tumor necrosis factor α-driven shift of Th17 lymphocytes toward a nonclassic Th1 phenotype in juvenile idiopathic arthritis. Arthritis Rheumatol 2014; 66: 1372-1377.
41. OShea JJ, Paul WE: Mechanisms underlying lineage commitment and plasticity of helper CD41 T cells. Science 2010; 327: 1098-1102.
42. Cosmi L, Maggi L, Santarlasci V, Capone M, Cardilicchia E, Frosali F, Querci V, Angeli R, Matucci A, Fambrini M, Liotta F, Parronchi P, Maggi E, Romagnani S, Annunziato F: Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4. J Allergy Clin Immunol 2010; 125: 222-230.
43. Wang YH, Voo KS, Liu B, Chen CY, Uygungil B, Spoede W, Bernstein JA, Huston DP, Liu YJ: A novel subset of CD4+T(H)2 memory/ effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J Exp Med 2010; 207: 2479-2491.
44. Cosmi L, Liotta F, Maggi E, Romagnani S, Annunziato F: Th17 cells: new players in asthma pathogenesis. Allergy 2011; 66: 989-998.
45. Maggi L, Capone M, Giudici F, Santarlasci V, Querci V, Liotta F, Ficari F, Maggi E, Tonelli F, Annunziato F, Cosmi L: CD4+CD161+ T lymphocytes infiltrate Crohns disease-associated perianal fistulas and are reduced by anti-TNF-α local therapy. Int Arch Allergy Immunol 2012; 161: 81-86.
46. Aerts NE, De Knop KJ, Leysen J, Ebo DG, Bridts CH, Weyler JJ, Stevens WJ, De Clerck LS: Increased IL-17 production by peripheral T helper cells after tumour necrosis factor blockade in rheumatoid arthritis is accompanied by inhibition of migration-associated chemokine receptor expression. Rheumatology (Oxford) 2010; 49: 2264-2272.
47. Smolen JS, Steiner G: Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov 2003; 2: 473-488.